biofilm formation – Page 3

Candida albicans Goliath cells pioneer biofilm formation

mycolabadmin

Researchers discovered that Candida albicans produces giant-sized cells called Goliath cells when zinc is scarce. These oversized cells are extremely sticky and can cling to plastic surfaces like catheters even when exposed to blood flow. Once attached, they form thicker, more resilient biofilms that can seed infections into the bloodstream, making Goliath cells particularly dangerous in hospital settings where catheters are commonly used.

Things you wanted to know about fungal extracellular vesicles (but were afraid to ask)

mycolabadmin

Fungal extracellular vesicles are tiny particles released by fungal cells that play important roles in how fungi cause disease and how our immune system responds. These particles can either help fight infections or make them worse depending on the type of fungus and conditions involved. Scientists are discovering that these vesicles could potentially be used as vaccines and may explain why some antifungal drugs stop working.

Ganoderma lucidum inspired silver nanoparticles and its biomedical applications with special reference to drug resistant Escherichia coli isolates from CAUTI

mycolabadmin

Researchers created tiny silver particles using a medicinal mushroom called Ganoderma lucidum to fight dangerous bacteria that resist antibiotics and are associated with urinary catheter infections. These nanoparticles were found to effectively kill drug-resistant bacteria, work as antioxidants better than a common antioxidant standard, and showed promise in killing breast cancer cells. This eco-friendly approach offers a natural alternative to conventional antibiotics for treating serious antibiotic-resistant infections.

The efficacy of luliconazole and caspofungin on planktonic and biofilm of Candida albicans from different sources

mycolabadmin

Candida albicans, a common yeast infection organism, can form tough protective structures called biofilms that resist antifungal medications. This study tested two antifungal drugs (luliconazole and caspofungin) against Candida in both regular form and biofilm form. The results showed that while these drugs work well against regular Candida cells, they are much less effective against biofilms, which require 15-171 times higher doses to be inhibited. The strongest biofilms came from vaginal infections, suggesting that different infection types may require different treatment approaches.

Study of the antagonistic relationship between gene expression biofilm of Aspergillus niger and Staphylococcus aureus that cause otomycosis

mycolabadmin

Researchers studied how bacteria (S. aureus) and fungi (A. niger) interact when both infect the ear canal, a condition called otomycosis. They found that bacteria significantly suppress the fungus’s ability to form protective biofilms by reducing the expression of genes needed for fungal growth. This antagonistic relationship suggests that mixed infections might actually be easier to treat than pure fungal infections, offering new insights for managing ear infections.

Characterization of ORF19.7608 (PPP1), a biofilm-induced gene of Candida albicans

mycolabadmin

Researchers studied a gene called PPP1 in Candida albicans, a common fungal infection in hospitals. They found that this gene is highly active when the fungus forms protective biofilms on medical devices like catheters. Although the protein appears in a distinctive spotted pattern only during biofilm formation, removing this gene did not prevent biofilm formation or affect how the fungus responds to stress or antifungal drugs.

Persister cells in human fungal pathogens

mycolabadmin

Some fungal infections fail to respond to antifungal drugs even when the fungus should be susceptible to treatment. This happens because certain fungal cells can enter a dormant ‘sleep-like’ state that helps them survive drug exposure. These dormant cells, called persisters, are able to hide from medications by reducing their metabolism and enhancing their protective defenses. Understanding how these persister cells form and survive could lead to better treatments for serious fungal infections.

Scanning electron microscopy of hyphal ectobiont bacteria within mycelial extracellular matrices

mycolabadmin

Researchers studied how bacteria attach to fungal filaments using advanced microscopy. They developed a special preparation method that removed outer biofilm layers to reveal how bacteria stick to fungal structures. The study found that bacteria form attachment structures with the fungal surface, with these structures being primarily produced by the fungus. This research helps us understand how bacteria and fungi interact in nature and in biotechnology.

Caspofungin therapy in prosthetic valve endocarditis and candidemia due to itraconazole-resistant Candida glabrata (Nakaseomyces glabratus): A case report

mycolabadmin

A 13-year-old boy developed a serious fungal infection of his heart valve after receiving an artificial valve replacement. The initial antibiotic (itraconazole) did not work because the fungus became resistant, likely by forming a protective biofilm. After identifying the resistant fungus through specialized testing, doctors switched to a different medication called caspofungin. The patient fully recovered with this new treatment and remained healthy during follow-up, showing that combination of precise identification and targeted treatment can overcome antibiotic resistance.

Editorial: Fungal virulence

mycolabadmin

This editorial discusses how fungi are becoming more dangerous to human health due to climate change and rising temperatures. Researchers are studying the specific mechanisms that make fungi harmful, including how they stick to human cells and form protective biofilms. The review highlights several important discoveries about different pathogenic fungi and suggests better ways to diagnose and treat fungal infections through understanding how environmental factors influence fungal behavior.

Research Topic: biofilm formation